5.4 Worsening of Psoriasis. Administration of PLAQUENIL to patients with psoriasis may precipitate a severe flare-up of psoriasis. Avoid PLAQUENIL in patients with psoriasis, unless the benefit to the patient outweighs the possible risk.
been reported in patients taking PLAQUENIL (see OVERDOSAGE). Therefore, PLAQUENIL should not be administered with other drugs that have the potential to prolong the QT interval (see DRUG INTERACTIONS). Worsening of psoriasis and porphyria: Use of PLAQUENIL in patients with psoriasis may precipitate a severe attack of psoriasis.
Administration of PLAQUENIL in patients with psoriasis may precipitate a severe flare-up of psoriasis. Administration of PLAQUENIL in patients with porphyria may exacerbate porphyria. Avoid PLAQUENIL in patients with psoriasis or porphyria, unless the benefit to the patient outweighs the possible risk.
indication. Psoriasis: Avoid use in patients with psoriasis unless Plaquenil
Plaquenil. Hydroxychloroquine sulfate Use of hydroxychloroquine in patients with psoriasis may precipitate a severe attack of psoriasis.
5.4 Worsening of Psoriasis. Administration of PLAQUENIL to patients with psoriasis may precipitate a severe flare-up of psoriasis. Avoid PLAQUENIL in patients with psoriasis, unless the benefit to the patient outweighs the possible risk.
by AG PARDASANI 2024 Cited by 91psoriasis, guttate psoriasis, localized pustular psoriasis and generalized pustular psoriasis. hydroxychloroquine (Plaquenil). The National
rheumatoid arthritis. Before AGEP has to be distinguished from psoriasis, although PLAQUENIL may precipitate attacks of psoriasis.
Hydroxychloroquine (brand name Plaquenil. Plaquenil Sulfate) is a The medication may rarely worsen psoriasis rash. Hydroxychloroquine may
Comments